Seek Labs Maps 25 Viral Families with BioSeeker, Advancing a Sequence-Driven Model for Antiviral Discovery Seek Labs, a private TechBio company focused on developing programmable platforms to decode, program, and…
Adaptyx Biosciences Presents First-In-Human Continuous Multi-Day Free Cortisol Data from Wearable Sensor at ADA, Showing Time-Resolved Hormone Signals for Metabolic and Health Insights Adaptyx Biosciences, a Stanford University spinout focused…
Corsair Pharma to Present Three Phase 1 Clinical Data Readouts for TRX-248 Transdermal System at the 2026 Pulmonary Hypertension Association Conference Corsair Pharma, Inc., a privately held biopharmaceutical company focused…
Neuraptive Therapeutics, Inc. Announces Key Organizational Updates to Advance Its Path Toward Commercialization Neuraptive Therapeutics has announced two key leadership appointments aimed at strengthening both its corporate governance and financial…
Ignite Proteomics Launches Prospective 10,000-Patient Oncology Registry to Assess Functional Proteomics in Cancer Therapy Selection Ignite Proteomics, LLC (“Ignite Proteomics”), a subsidiary of Aditxt, Inc. (NASDAQ: ADTX), has announced the…
Vizgen® to Advance Cell Atlas Research with New Volumetric Tissue Mapping Spatial Data and Services at HCA 2026 Meeting Vizgen, Inc., a spatial multiomics company and developer of the MERSCOPE…
Vertex Presents New ALYFTREK® Data at the European Cystic Fibrosis Conference Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) has announced new clinical and long-term follow-up data highlighting the expanding impact of its…
Biogen’s Salanersen Granted FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy Biogen Inc. (Nasdaq: BIIB) has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation…
WuXi Biologics Singapore CRDMO Hub Achieves Modular Topping-Out of Drug Product Facility WuXi Biologics (2269.HK), a global leader in Contract Research, Development and Manufacturing Organization (CRDMO) services, has announced the…
Teva Presents New AUSTEDO® and AUSTEDO XR® Data Showing Patient- and Caregiver-Reported Improvements in Huntington’s Disease Chorea Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE:…
OrsoBio to Present Preclinical and Clinical Data from Its Mitochondrial Protonophore Portfolio at ADA 2026 Scientific Sessions OrsoBio, Inc., a clinical-stage biopharmaceutical company focused on developing novel treatments for obesity…
CicadaBio to Present CC-18, a Novel GLP-1/ActRII Fusion Protein for Muscle-Sparing Weight Loss, at ADA 2026 CicadaBio has announced new preclinical findings for CC-18, its investigational dual-pathway fusion protein targeting…